Autolus Therapeutics Ltd reported $-72.47M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -72.47M 845K Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Silence Therapeutics USD -12.46M 13.78M Dec/2025